Erase AF - A Great First Step

There was a strong trend towards less atrial fibrillation in the active arm. This makes me think there's a strong possibility of performance bias. The problem with Erase AF is early randomization dilutes the groups with patients who don't even have low voltage areas. If low voltage areas are predictive of more atrial structural disease, the PVI alone strategy could have included sicker patients who were more likely to recur. So in sum, this trial is a great first step and a hearty thank you to the Erase AF authors. It's amazing and they've set an example of what we should be doing in EP.

Transcript

Play full episode

Transcript

Episode notes

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app